COPD Clinical Trials in Montreal, Quebec
8 recruitingMontreal, Quebec, Canada
Showing 1–8 of 8 trials
Recruiting
Phase 3
A Study to Investigate the Efficacy and Safety of Tezepelumab in Adult Participants With Moderate to Very Severe COPD (D5241C00006)
Chronic Obstructive Pulmonary Disease (COPD)
AstraZeneca990 enrolled297 locationsNCT06883305
Recruiting
Phase 3
A Study Evaluating the Efficacy of Budesonide, Glycopyrronium and Formoterol Fumarate Metered Dosed Inhaler on Cardiopulmonary Outcomes in Chronic Obstructive Pulmonary Disease
COPD, Chronic Obstructive Pulmonary Disease
AstraZeneca5,000 enrolled917 locationsNCT06283966
Recruiting
Phase 3
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
Chronic Obstructive Pulmonary Disease (COPD)
Hoffmann-La Roche1,290 enrolled462 locationsNCT05595642
Recruiting
Not Applicable
Routine vs On-demand ECMO for Lung Transplantation
Respiratory FailurePulmonary FibrosisCOPD, Chronic Obstructive Pulmonary Disease+1 more
Centre hospitalier de l'Université de Montréal (CHUM)218 enrolled4 locationsNCT06615492
Recruiting
Not Applicable
The Effects of Oscillatory Positive Expiratory Pressure (OPEP) Therapy in Patients With COPD
COPD
McGill University Health Centre/Research Institute of the McGill University Health Centre32 enrolled1 locationNCT06614959
Recruiting
Predicting Acute Exacerbations of COPD Using Wearable Devices and Remote Monitoring Technology With AI/ML Models
COPDAE COPD
McGill University Health Centre/Research Institute of the McGill University Health Centre50 enrolled1 locationNCT06802003
Recruiting
Assessing Optimal Inhaler Strategies During Acute Exacerbations of COPD (AECOPDs) Using Oscillometry
COPDCOPD Exacerbation Acute
McGill University Health Centre/Research Institute of the McGill University Health Centre43 enrolled1 locationNCT06495047
Recruiting
Phase 2
Oral Supplementation During PR Participation in COPD
COPD
McGill University Health Centre/Research Institute of the McGill University Health Centre10 enrolled1 locationNCT06324214